What health care providers actually want from artificial intelligence

In a market flooded with artificial intelligence promises, health care leaders now prioritize pragmatic, pressure-tested solutions that address staffing shortages, clinician burnout, costs, and patient bottlenecks. Vendors that demonstrate integration, real-world validation, explainability, and clear return on investment are more likely to gain traction.

Health care providers are no longer swayed by flashy demonstrations or abstract potential. They want artificial intelligence solutions that fix concrete problems such as staffing shortages, clinician burnout, rising costs, and patient flow bottlenecks. Examples cited include natural language processing to reduce documentation burden and streamline coding, and predictive analytics to optimize staffing and manage patient throughput. If a product does not target these operational pain points and deliver measurable benefits, it is unlikely to win serious buyer interest.

Evidence of real-world performance is essential. Developers must use high-quality, well curated real-world data to avoid misleading results and refine models. Hospitals expect independent third-party validation, pilot projects, peer-reviewed publications, or documented case studies to prove a solution works in actual care settings. Mayo Clinic Platform is highlighted as offering a rigorous independent evaluation process where clinical, data science, and regulatory experts assess intended use, proposed value, and clinical and algorithmic performance, helping innovators build credibility with health care leaders.

Seamless integration into existing systems and workflows is a baseline requirement. Compatibility with major electronic health record platforms, robust application programming interfaces, and smooth data ingestion are now expected. Custom integrations that demand significant IT resources or create duplicative work are deal breakers. Programs such as Mayo Clinic Platform Solutions Studio are presented as ways to reduce implementation friction through single implementation, expert guidance, and accelerated adoption.

Trust, explainability, and transparency are critical adoption factors. Providers are wary of black-box systems and want models that offer understandable explanations clinicians can relay to peers, patients, and regulators. The article notes research from McKinsey showing that embedding explainability reduces risk and improves adoption, performance outcomes, and financial returns. Vendors who demystify their models and publish transparent performance metrics gain an edge.

Finally, buyers want clear return on investment, low implementation burden, strong training and support, and proactive alignment with regulatory and compliance needs such as HIPAA and emerging governance around bias mitigation. Successful vendors also demonstrate domain expertise in clinical care and operations and commit to long-term partnerships rather than short-term sales. The content was produced by Mayo Clinic Platform and not by MIT Technology Review’s editorial staff.

62

Impact Score

Can an artificial intelligence doppelganger help me do my job

Digital clones combine hyperrealistic video, lifelike voice cloning, and conversational models to mimic a person. Startups promise that an artificial intelligence doppelgänger can scale personal interactions, but practical limits and safety concerns remain.

Accenture buys generative Artificial Intelligence business

Accenture has agreed to acquire NeuraFlash, a generative Artificial Intelligence consulting company, for an undisclosed sum subject to customary closing conditions. The deal will add about 510 staff and bolster Accenture’s Salesforce and managed services capabilities.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.